inflammatory bowel disease

Conference Coverage

Anti-integrin Therapy Offers Benefits in the Management of IBD

12/12/2019

Brian Feagan, MD, discussed anti-integrin therapy for the treatment of patients with IBD during his presentation at the 2019 AIBD Meeting.

Brian Feagan, MD, discussed...

12/12/2019

Advances in Inflammatory Bowel Disease Network

Podcasts

Christina Ha, MD, on Treating IBD in the Elderly

11/27/2019

Dr Ha, from Cedars-Sinai Medical Center, discusses the management of inflammatory bowel disease in the elderly, the potential for undertreatment, balancing medication interactions, and more.

Dr Ha, from Cedars-Sinai Medical...

11/27/2019

Advances in Inflammatory Bowel Disease Network

Podcasts

David Hudesman, MD, on When to Withdraw Medication in IBD

10/31/2019

Dr Hudesman, from NYU Langone Health, discusses when to withdraw medication among patients with inflammatory bowel disease, the risks associated with recurrence, if medication can be restarted, and more.

Dr Hudesman, from NYU Langone...

10/31/2019

Advances in Inflammatory Bowel Disease Network

Q&As

4 Questions About the Expected Increase in Biosimilars for IBD

10/25/2019

Adam Cheifetz, MD, from Beth Israel Deaconess Medical Center and Harvard Medical School, answers our questions about the expected increase in the number of available biosimilars for the management of IBD and the challenges gastroenterologists...

Adam Cheifetz, MD, from Beth...

10/25/2019

Advances in Inflammatory Bowel Disease Network

Q&As

4 Questions About Discontinuing Biologic Treatment of IBD During Pregnancy

10/08/2019

Brindusa Truta, MAS, MD, from Johns Hopkins Medicine, answers our questions about her study that evaluated pregnancy outcomes among mothers with IBD who discontinued therapy with infliximab early vs late during pregnancy.

Brindusa Truta, MAS, MD, from...

10/08/2019

Advances in Inflammatory Bowel Disease Network

News

Practical Implications for Positioning Therapy in Inflammatory Bowel Disease

09/07/2019

Edward Barnes, MD, MPH, discussed practical implications to consider when positioning medications in the management of IBD during his presentation at the Advances in Inflammatory Bowel Diseases Regional in Baltimore, Maryland.

Edward Barnes, MD, MPH,...

09/07/2019

Advances in Inflammatory Bowel Disease Network

Podcasts

Raymond Cross Jr, MD, on Key Concepts in IBD at the AIBD Regional Meeting in Baltimore

09/03/2019

Raymond Cross Jr, MD, from the University of Maryland, is a cochair of the Advances in Inflammatory Bowel Diseases Regional Meeting in Baltimore, Maryland. In this podcast, he provides highlights of the upcoming meeting and explains key...

Raymond Cross Jr, MD, from the...

09/03/2019

Advances in Inflammatory Bowel Disease Network

Poll

Poll: Extraintestinal Manifestations in IBD

08/29/2019

What is a challenging extraintestinal manifestation of IBD that you have encountered in your practice? Let us know by taking our quick poll.

What is a challenging...

08/29/2019

Advances in Inflammatory Bowel Disease Network

Q&As

5 Questions About Dermatologic and Rheumatologic Manifestations in IBD

08/28/2019

Hans Herfarth, MD, PhD, from the University of North Carolina at Chapel Hill, answers our questions about dermatologic and rheumatologic complications in the management of IBD.

Hans Herfarth, MD, PhD, from the...

08/28/2019

Advances in Inflammatory Bowel Disease Network

Videos

Maria Abreu, MD, on Developing a Cure for Inflammatory Bowel Disease

08/22/2019

In this video, Maria Abreu, MD, from the University of Miami, highlights the challenges in developing a cure for inflammatory bowel disease (IBD), the next steps towards a cure, and more.

In this video, Maria Abreu, MD,...

08/22/2019

Advances in Inflammatory Bowel Disease Network